Insulin-like growth factor-binding protein-3 protease activity in Snell normal and Pit-1 deficient dwarf mice

Journal of Endocrinology

Volumn 157, Issue 2, 1998, Pages 295-303

  Koedam, J A ^a   Hoogerbrugge, C M ^a   Van Buul Offers, S C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,10 PHENANTHROLINE; EDETIC ACID; PROTEINASE; SOMATOMEDIN BINDING PROTEIN 3; TRANSCRIPTION FACTOR PIT 1;

ACROMEGALY; ARTICLE; BIOAVAILABILITY; DWARFISM; ENZYME ACTIVITY; ENZYME DEFICIENCY; GENE MUTATION; GROWTH HORMONE DEFICIENCY; HUMAN; HUMAN CELL; HYPOPHYSECTOMY; PRIORITY JOURNAL; PROTEIN DEGRADATION; RECEPTOR AFFINITY;

ANIMALS; BLOTTING, WESTERN; DNA-BINDING PROTEINS; EDETIC ACID; ENDOPEPTIDASES; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; MALE; MICE; MICE, MUTANT STRAINS; PHENANTHROLINES; PREGNANCY; RATS; RATS, WISTAR; TRANSCRIPTION FACTOR PIT-1; TRANSCRIPTION FACTORS;

EID: 0031809517     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1570295     Document Type: Article

References (46)

1. Bang P, Brismar K & Rosenfeld RG 1994 Increased proteolysis of insulin-like growth factor-binding protein-3 (IGFBP-3) in noninsulin-dependent diabetes mellitus serum, with elevation of a 29-kilodalton (kDa) glycosylated IGFBP-3 fragment contained in the approximately 130- to 150-kDa ternary complex. Journal of Clinical Endocrinology and Metabolism 78 1119-1127.
2. Baxter RC 1994 Insulin-like growth factor binding proteins in the human circulation: A review. Hormone Research 42 140-144.
3. Baxter RC & Martin JL 1986 Radioimmunoassay of growth hormone-dependent insulin-like growth factor binding protein in human plasma, Journal of Clinical Investigation 78 1504-1512.
4. Bereket A, Lang CH, Blethen SL, Fan J, Frost RA & Wilson TA 1995 Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: A possible role for insulin in the regulation of IGFBP-3 protease activity. Journal of Clinical Endocrinology and Metabolism 80 2282-2288.
5. Binoux M, Lalou C, Lassarre C, Blat C & Hossenlopp P 1993 Limited proteolysis of insulin-like growth factor binding protein-3 (IGFBP-3): A physiological mechanism in the regulation of IGF bioavailability. Advances in Experimental and Medical Biology 343 293-300.
6. Blat C, Villaudy J & Binoux M 1994 In vivo proteolysis of serum insulin-like growth factor (IGF) binding protein-3 results in increased availability of IGF to target cells. Journal of Clinical Investigation 93 2286-2290.
7. Blum WF, Ranke MB, Kietzmann K, Gauggel E, Zeisel HJ & Bierich JR 1990 A specific radioimmunoassay for the growth hormone (GH)-dependent somatomedin-binding protein: Its use for diagnosis of GH deficiency. Journal of Clinical Endocrinology and Metabolism 70 1292-1298.
8. Campbell PG, Novak JF, Yanosick TB & McMaster JH 1992 Involvement of the plasmin system in dissociation of the insulin-like growth factor-binding protein complex. Endocrinology 130 1401-1412.
9. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC & Rosenfeld RG 1992 Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. Journal of Clinical Endocrinology and Metabolism 75 1046-1053.
10. Cohen P, Peehl DM, Graves HCB & Rosenfeld RG 1994 Biological effects of prostate specific antigen as an insulin-like growth factor binding protein-3 protease. Journal of Endocrinology 142 407-415.
11. Conover CA & De Leon DD 1994 Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. Journal of Biological Chemistry 269 7076-7080.
12. Coulson VJ, Macaulay JAH, Wass JAH & Holly JMP 1991 The presence of a circulating protease for IGF binding protein 3 (IGFBP-3) in patients with cancer of the lung, breast, or head and neck. Journal of Endocrinology 131 (Suppl) Abstract 50.
13. Cwyfan Hughes SC, Cotterill AM, Molloy AR, Cassell TB, Braude N, Hinds CJ, Wass JAH & Holly JMP 1992 The induction of specific proteases for insulin-like growth factor-binding proteins following major heart surgery. Journal of Endocrinology 135 135-145.
14. Davenport ML, Clemmons DR, Miles MV, Camacho-Hubner C, D'Ercole AJ & Underwood LE 1990 Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology 127 1278-1286.
15. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE & Clemmons DR 1992a Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. Journal of Clinical Endocrinology and Metabolism 75 590-595.
16. Davenport ML, Pucilowska J, Clemmons DR, Lundblad R, Spencer JA & Underwood LE 1992b Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy. Endocrinology 130 2505-2512.
17. Davies SC, Wass JAH, Ross RJM, Cotterill AM, Buchanan CR, Coulson VJ & Holly JMP 1991 The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. Journal of Endocrinology 130 469-473.
18. Fielder PJ, Thordarson G, Talamantes F & Rosenfeld RG 1990 Characterization of insulin-like growth factor binding proteins (IGFBPs) during gestation in mice: Effects of hypophysectomy and an IGFBP-specific serum protease activity. Endocrinology 127 2270-2280.
19. Fielder PJ, Mortensen DL, Mallet P, Carlsson B, Baxter RC & Clark RG 1996 Differential long-term effects of insulin-like growth factor-I (IGF-I), growth hormone (GH), and IGF-I plus GH on body growth and IGF binding proteins in hypophysectomized rats. Endocrinology 137 1913-1920.
20. Fowlkes JL, Suzuki K, Nagase H & Thrailkill KM 1994 Proteolysis of insulin-like growth factor binding protein-3 during rat pregnancy: A role for matrix metalloproteinases. Endocrinology 135 2810-2813.
21. Gargosky SE, Pham HM, Wilson KF, Liu F, Giudice LC & Rosenfeld RG 1992 Measurement and characterization of insulin-like growth factor binding protein-3 in human biological fluids: Discrepancies between radioimmunoassay and ligand blotting. Endocrinology 131 3051-3060.
22. Gargosky SE, Nanto-Salonen K, Tapanainen P & Rosenfeld RG 1993 Pregnancy in growth hormone-deficient rats: Assessment of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs) and IGFBP protease activity. Journal of Endocrinology 136 479-489.
23. Gargosky SE, Tapanainen P & Rosenfeld RG 1994 Administration of growth hormone (GH), but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150-kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology 134 2267-2276.
24. Giudice LC, Farrell EM, Pham H, Lamson G & Rosenfeld RG 1990 Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity. Journal of Clinical Endocrinology and Metabolism 71 806-816.
25. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S & Binoux M 1986 Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Analytical Biochemistry 154 138-143.
26. Hossenlopp P, Segovia B, Lassarre C, Roghani M, Bredon M & Binoux M 1990 Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. Journal of Clinical Endocrinology and Metabolism 71 797-805.
27. Jones JI & Clemmons DR 1995 Insulin-like growth factors and their binding proteins: Biological actions. Endocrine Reviews 16 3-34.
28. Lamson G, Giudice LC & Rosenfeld RG 1991 A simple assay for proteolysis of IGFBP-3. Journal of Clinical Endocrinology and Metabolism 72 1391-1393.
29. Lee DY, Cohen P, Krensky AM, Rosenfeld RG & Yorgin PD 1993 Insulin-like growth factor binding protein-3 protease activity in the urine of children with chronic renal failure. Pediatric Nephrology 7 416-423.
30. Li S, Crenshaw EB III, Rawson EJ, Simmons DM, Swanson LW & Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1. Nature 347 528-533.
31. Liu F, Baxter RC & Hintz RL 1992 Characterization of the high molecular weight insulin-like growth factor complex in term pregnancy serum. Journal of Clinical Endocrinology and Metabolism 75 1261-1267.
32. Muller HL, Oh Y, Gargosky SE, Wilson KF, Lehrnbecher T & Rosenfeld RG 1994 Insulin-like growth factor binding protein-3 concentrations and insulin-like growth factor binding protein-3 protease activity in sera of patients with malignant solid tumors or leukemia. Pediatric Research 35 720-724.
33. Orlowski CC & Chernausek SD 1988 Discordance of serum and tissue somatomedin levels in growth hormone-stimulated growth in the rat. Endocrinology 123 44-19.
34. Pell JM & Bates PC 1992 Differential actions of growth hormone and insulin-like growth factor-I on tissue protein metabolism in dwarf mice. Endocrinology 130 1942-1950.
35. Rajah R, Bhala A, Nunn SE, Peehl DM & Cohen P 1996 7S nerve growth factor is an insulin-like growth factor-binding protein protease. Endocrinology 137 2676-2682.
36. Rutishauser J, Schmid C, Hauri C, Froesch ER & Zapf J 1993 Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Letters 334 23-26.
37. Shimasaki S & Ling N 1991 Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and 6). Progress in Growth Factor Research 3 243-266.
38. Smeets T & Van Buul-Offers SC 1983 The influence of growth hormone, somatomedins, prolactin and thyroxine on the morphology of the proximal tibial epiphysis and growth plate of Snell dwarf mice. Growth 47 160-173.
39. Sommer A, Maack CA, Spratt SK, Mascarenhas D, Tressel TJ, Rhodes ET, Lee R, Roumas M, Tatsuno GP, Flynn JA, Gerber N, Taylor J, Cudny H, Nanney L, Hunt TK & Spencer EM 1991 Molecular genetics and actions of recombinant insulin-like growth factor binding protein-3. In Modern Concepts of Insulin-like Growth Factors, pp 715-728. Ed. EM Spencer. New York: Elsevier.
40. Tressel TJ, Tatsuno GP, Spratt K & Sommer A 1991 Purification and characterization of human recombinant insulin-like growth factor binding protein 3 expressed in Chinese hamster ovary cells. Biochemical and Biophysical Research Communications 178 625-633.
41. Van Buul-Offers SC 1983 Hormonal and other inherited growth disturbances in mice with special reference to the Snell dwarf mouse. A review. Acta Endocrinologica 103 (Suppl 258) 1-47.
42. Van Buul-Offers SC & Van den Brande JL 1978 The Snell-dwarf mouse I. General growth pattern, before and during growth hormone and thyroxine therapy. Acta Endocrinologica 89 632-645.
43. Van Buul-Offers SC, Ueda I & Van den Brande JL 1986 Biosynthetic somatomedin-C (SM-C/IGF-I) increases the length and weight of Snell dwarf mice. Pediatric Research 20 825-827.
44. Van Buul-Offers SC, Bloemen RJ, Reijnen-Gresnigt MG, Van Leiden HA, Hoogerbrugge CM & Van den Brande JL 1994a Insulin-like growth factor I and II and their binding proteins during postnatal development of dwarfed Snell mice before and during growth hormone and thyroxine therapy. Journal of Endocrinology 143 191-198.
45. Van Buul-Offers SC, Reijnen-Gresmgt MG, Hoogerbrugge CM, Bloemen RJ, Kuper CF & Van den Brande JL 1994b Recombinant insulin-like growth factor-II inhibits the growth-stimulating effect of growth hormone on the liver of Snell dwarf mice. Endocrinology 135 977-985.
46. Van Buul-Offers SC, De Haan K, Reijnen-Gresnigt MG, Meinsma D, Jansen M, Oei SL, Bonte EJ, Sussenbach JS & Van den Brande JL 1995 Overexpression of human IGF-II in transgenic mice causes increased growth of the thymus. Journal of Endocrinology 144 491-502.